Targeting Rare Diseases and Critical Care.

Over the past 25 years, the group has become an established provider of integrated therapy solutions from its headquarters in Vienna, its subsidiaries and representative offices throughout Europe and the Middle East, as well as through partners worldwide.
Since the very start the company has been focused on the individual needs and treatments of patients. Based on its research-centered approach, AOP Health has a profound understanding of rare diseases and critical care. Therefore, the company has been able to position itself as an innovative front-runner in the development of effective therapies and drugs.

Whether a disease is defined as a rare disease depends on the frequency of its occurrence in the population. However, from the global point of view the definition is not consistent. Thus, in Europe those diseases that occur in less than 5 per 10,000 residents are defined as rare diseases.